![PRD_000207 PRD_000207](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000207.svg) | PRD_000207 | Name: | Decaplanin | Formula: | C72 H86 Cl N9 O28 | Description: | DECAPLANIN IS A TRICYCLIC GLYCOPEPTIDE. THE SCAFFOLD IS A HEPTAPEPTIDE WITH THE CONFIGURATION D-D-L-D-D-L-L,
GLYCOSYLATED | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000209 PRD_000209](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000209.svg) | PRD_000209 | Name: | Teicoplanin A2-2 beta-D-Glucopyranuronic acid | Formula: | C88 H97 Cl2 N9 O33 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000976 PRD_000976](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000976.svg) | PRD_000976 | Name: | N-acetyl-L-valyl-L-alpha-glutamyl-N-[(2S)-1-carboxy-3-oxopropan-2-yl]-L-isoleucinamide | Formula: | C22 H36 N4 O9 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000210 PRD_000210](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000210.svg) | PRD_000210 | Name: | Teicoplanin Aglycone | Formula: | C58 H45 Cl2 N7 O18 | Description: | TEICOPLANIN AGLYCON IS THE NONSUGAR COMPONENT OF
TEICOPLANIN, CONSISTING OF THE TETRACYCLIC
HEPTAPEPTIDE ONLY. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000977 PRD_000977](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000977.svg) | PRD_000977 | Name: | 1-acetyl-L-prolyl-L-threonyl-N-[(2R,3S)-4-chloro-3-hydroxy-1-(4-hydroxyphenyl)butan-2-yl]-L-serinamide | Formula: | C24 H35 Cl N4 O8 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000211 PRD_000211](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000211.svg) | PRD_000211 | Name: | A40926 | Formula: | C88 H95 Cl2 N9 O34 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000212 PRD_000212](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000212.svg) | PRD_000212 | Name: | Microcystin LR | Formula: | C49 H75 N10 O12 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000980 PRD_000980](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/UBX.svg) | PRD_000980 | Name: | N-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-N-methyl-L-leucinamide | Formula: | C16 H26 N3 O5 P | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000981 PRD_000981](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/UBY.svg) | PRD_000981 | Name: | N-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-leucyl-L-alanine | Formula: | C18 H28 N3 O7 P | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000213 PRD_000213](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000213.svg) | PRD_000213 | Name: | motuporin | Formula: | C40 H57 N5 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000982 PRD_000982](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/UBZ.svg) | PRD_000982 | Name: | (2S)-2-({N-[(R)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-leucyl}amino)butanoic acid | Formula: | C19 H30 N3 O7 P | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000214 PRD_000214](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000214.svg) | PRD_000214 | Name: | NODULARIN-R | Formula: | C41 H61 N8 O10 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000215 PRD_000215](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000215.svg) | PRD_000215 | Name: | DIHYDROMICROCYSTIN-LA | Formula: | C46 H69 N7 O12 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000983 PRD_000983](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/UBW.svg) | PRD_000983 | Name: | N-[(R)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-leucyl-L-norvaline | Formula: | C20 H32 N3 O7 P | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000216 PRD_000216](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000216.svg) | PRD_000216 | Name: | LEUPEPTIN | Formula: | C20 H41 N6 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000984 PRD_000984](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/UBV.svg) | PRD_000984 | Name: | N-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-leucyl-L-isoleucine | Formula: | C21 H34 N3 O7 P | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000985 PRD_000985](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/UBU.svg) | PRD_000985 | Name: | N-[(R)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-N-ethyl-L-leucinamide | Formula: | C17 H28 N3 O5 P | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000217 PRD_000217](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000217.svg) | PRD_000217 | Name: | Daptomycin | Formula: | C72 H101 N17 O26 | Description: |
DAPTOMYCIN IS AN ACIDIC CYCLIC LIPOPEPTIDE.
THE SCAFFOLD IS MADE OF TWO PARTS:
(1) THREE RESIDUES N-TERM EXOCYCLIC PART
(2) A DECAPEPTIDE LACTONE RING DERIVED FROM
CYCLISATION OF THR3 SIDE CHAIN ONTO THE C-TER
CARBOXYL GROUP
THE N-DECANOYL FATTY ACID IS LINKED TO THE
MAIN BODY OF THE MOLECULE VIA N-TERM ACYLATION. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000986 PRD_000986](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/UBT.svg) | PRD_000986 | Name: | N-[(R)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-leucylglycine | Formula: | C17 H26 N3 O7 P | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000219 PRD_000219](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000219.svg) | PRD_000219 | Name: | GRAMICIDIN S | Formula: | C60 H92 N12 O10 | Description: | GRAMICIDIN S IS A DECAPEPTIDE,
RESIDUES 1 AND 10 FORM A PEPTIDE BOND
RESULTING IN CYCLIZATION. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000220 PRD_000220](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000220.svg) | PRD_000220 | Name: | FEGLYMYCIN | Formula: | C95 H97 N13 O30 | Description: | FEGLYMYCIN IS A LINEAR HELICAL TRIDECAMER PEPTIDE | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000987 PRD_000987](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/UBS.svg) | PRD_000987 | Name: | N-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-L-leucyl-L-valine | Formula: | C20 H32 N3 O7 P | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000221 PRD_000221](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000221.svg) | PRD_000221 | Name: | Nosiheptide | Formula: | C51 H46 N13 O11 S6 | Description: | NOSIHEPTIDE IS A HETROCYCLIC THIOPEPTIDE, CONSISTING OF FIVE THIAZOLES AND ONE 3-HYDROXYPYRIDINE RINGS. A MODIFIED
INDOLE RING NO1(14) IS LINKED VIA THE SIDE CHAINS OF 3-HYDROXY 3GL(6) AND CYS(8). THE OBSERVED C-TERMINAL AMINO GROUP
NH2(13) IS LIKELY TO BE A POST-TRANSLATIONAL DECARBOXYLATED REMNANT OF A SER C-TERMINAL RESIDUE | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000988 PRD_000988](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000988.svg) | PRD_000988 | Name: | N-benzoyl-L-norleucyl-6-ammonio-L-norleucyl-N~5~-[amino(iminio)methyl]-N-[(2S)-5-carbamimidamido-1-hydroxypentan-2-yl]-L-ornithinamide | Formula: | C31 H57 N11 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000222 PRD_000222](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000222.svg) | PRD_000222 | Name: | RAMOPLANIN A2 | Formula: | C119 H154 Cl N21 O40 | Description: | RAMOPLANIN A2 IS A CYCLIC HEPTADECAMER
LIPOGLYCODEPSIPEPTIDE.
THE SCAFFOLD IS A HEPTA CYCLIC PEPTIDE
GLYCOSYLATED BY ONE DISACCHARIDE AND A FATTY ACID
AT THE N-TERM. | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|